New 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives having the chemical structure of general formula (I), and pharmaceutically acceptable salts thereof are disclosed, as well as processes for their preparation and to pharmaceutical compositions containing them and their use in the treatment, prevention or suppression of pathological conditions, diseases and disorders susceptible of being improved by inhibition of PDE7.
本发明公开了具有一般式(I)的
化学结构的新4-
氨基
噻吩[2,3-d]
嘧啶-6-腈衍
生物及其药学上可接受的盐,以及制备它们的方法和包含它们的制药组合物,以及它们在治疗、预防或抑制通过抑制PD
E7改善的病理状况、疾病和障碍中的使用。